" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Translational Medicine (EUSTM-2013)

14 Oct 2013 - 16 Oct 2013 - Mondorf-les-Bains, Luxembourg



Bookmark and Share


The Annual Congress of the European Society for Translational Medicine & Global Network Conference on Translational Medicine (EUSTM-2013) will be held in Mondorf-les-Bains, Luxembourg on October 14-16, 2013.It covers topics such as:

Personalized Medicine

Translational Research: Novel Findings and Updates in Pathophysiology and Diagnostics

Biomarkers

Cell Therapy and Regenerative Medicine

Translational Bioinformatics & Data Management

Omics Sciences and Applications in Translational Research

Translational Pharmacology & Biobanking

Translational Medicine in Pre-clinical and Clinical Development and in the Post-Registration Phase

Public Health & Epidemiology in Translational Medicine

The Annual EUSTM-2013 Congress brings together attendees interested in translational medicine from

Research institutions

Academic centers

Governments

Regulatory agencies

Members of patient organizations

Practicing physicians

Medtech and medical instruments companies

Pharma and biotech industries

Clinical research organizations

Consultancy firms

Data management companies

EUSTM-2013 will bring together world leaders from the industry, academic centers, research institutions, regulatory agencies, and governments to discuss translational approaches and tools that will accelerate the research and development of novel diagnostics and therapeutics thereby reducing high cost budgets and attrition rates. Participants will also include practicing physicians with clinical experience in various therapeutic areas and members of patient organizations. EUSTM-2013 will offer an interdisciplinary forum to address current challenges in translational medicine and highlight novel solutions. The conference represents a unique opportunity for global networking. Pharma and biotech industries, medtech and medical instruments companies, consultancy firms, clinical research organizations and data management companies will showcase and exhibit their products and services.




Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!